COMMUNIQUÉS West-GlobeNewswire

Plus Therapeutics Provides Business Update on REYOBIQ™ Clinical Program and U.S. CNSide® Commercialization
22/01/2026
Expands CNSide Clinical License in State of Pennsylvania HOUSTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision [...]
Invivyd Announces Partnership with World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention
22/01/2026
The educational campaign will focus on teaching the American public about antibodies and preventing infectious disease The collaboration will advance public understanding of antibodies as a centerpiece of modern [...]
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026
22/01/2026
Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new Orion cortical stimulation system for visual perception, designed to treat most common forms [...]
ProPhase Labs Uplists from Pink Sheets to OTC Market
22/01/2026
UNIONDALE, NY, Jan. 22, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (“ProPhase” or the “Company”), a diversified life sciences and diagnostics company, today announced that its common stock has been approved and [...]
Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.
22/01/2026
LAUPHEIM, Germany and MILFORD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that [...]
Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio
22/01/2026
NEW YORK and SAVONA, Italy, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic [...]
Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01
22/01/2026
STAFFORD, Texas, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile
22/01/2026
Amendment reduces and simplifies royalty structure on Teverelix ® from ~4% to 2% while preserving global rights and IP control The Company is developing Teverelix ® as a first in class market product for Acute Urinary [...]
Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
22/01/2026
PARIS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery technology, is [...]
Resalis Therapeutics Appoints Sandor Batkai as Medical Director
22/01/2026
Torino, Italy, January 22 – Resalis Therapeutics , a biotechnology company pioneering microRNA-targeted therapies, today announced the appointment of Sandor Batkai , MD, PhD, as Medical Director. Dr. Batkai is a [...]
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
22/01/2026
ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, [...]
Care@Home for Life Appoints Aurelian Anghelusiu as Chief Relationship Officer to Lead Human-Centered Growth Strategy
22/01/2026
Miami, FL, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Care@Home for Life, a company dedicated to redefining how Americans age at home, today announced the appointment of Aurelian Anghelusiu as Chief Relationship Officer. In this [...]
ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement
22/01/2026
Investigational ARC-BCI ® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other movement disabilities ARC-BCI is the world’s first and most advanced purpose- [...]
BioAge Announces Pricing of Upsized $115.0 Million Public Offering
22/01/2026
EMERYVILLE, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (Nasdaq: BIOA) ("BioAge", “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic [...]
Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
22/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the pricing of an upsized underwritten public [...]
Erasca Announces Pricing of Upsized Public Offering of Common Stock
22/01/2026
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]
Romeo Orthopaedics Launches Specialty Shoulder and Elbow Clinic in Burr Ridge, Illinois
22/01/2026
Dr. Anthony A. Romeo Brings Over 30 Years of Expertise to New Practice Burr Ridge, Illinois, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Romeo Orthopaedics , founded by renowned orthopaedic surgeon Dr. Anthony A. Romeo, today [...]
BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business
21/01/2026
Accelerates expansion of BioStem’s commercial organization through integration of an experienced national sales force Expands access to major GPO networks, strengthening BioStem’s position across hospital settings Barry [...]
Colostrum Supplements for Weight Loss: How Consumers Compare IgG Potency, Gut Health Claims, and Sourcing Standards in 2026
22/01/2026
As Searches for "Best Colostrum Supplement for Weight Loss" Rise, Cowboy Colostrum Emerges as One Example Consumers Are Evaluating New York, NY, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for [...]

Pages